IRIS
LUISETTI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.109
AS - Asia 5.379
EU - Europa 4.244
SA - Sud America 642
AF - Africa 159
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 17.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.960
CN - Cina 2.726
SG - Singapore 1.184
IE - Irlanda 931
UA - Ucraina 779
DE - Germania 525
HK - Hong Kong 524
FI - Finlandia 476
BR - Brasile 471
VN - Vietnam 430
RU - Federazione Russa 383
SE - Svezia 269
FR - Francia 249
GB - Regno Unito 248
IT - Italia 173
IN - India 93
ZA - Sudafrica 76
CA - Canada 72
AR - Argentina 59
BD - Bangladesh 57
AU - Australia 51
MX - Messico 49
JP - Giappone 48
IQ - Iraq 44
BE - Belgio 34
EC - Ecuador 32
PK - Pakistan 32
NL - Olanda 28
IR - Iran 26
TR - Turchia 25
VE - Venezuela 25
ES - Italia 24
PT - Portogallo 24
CL - Cile 21
PL - Polonia 21
CO - Colombia 18
ID - Indonesia 18
PH - Filippine 18
SA - Arabia Saudita 18
UZ - Uzbekistan 17
EG - Egitto 15
MY - Malesia 15
AT - Austria 14
KE - Kenya 14
CZ - Repubblica Ceca 13
KR - Corea 13
TN - Tunisia 12
TW - Taiwan 12
IL - Israele 11
LT - Lituania 11
MA - Marocco 11
JO - Giordania 10
AL - Albania 8
AZ - Azerbaigian 8
KZ - Kazakistan 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 6
LB - Libano 6
TH - Thailandia 6
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
LV - Lettonia 5
OM - Oman 5
CH - Svizzera 4
HR - Croazia 4
HU - Ungheria 4
MU - Mauritius 4
NG - Nigeria 4
NI - Nicaragua 4
PE - Perù 4
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GR - Grecia 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
SN - Senegal 3
SY - Repubblica araba siriana 3
CY - Cipro 2
GH - Ghana 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MM - Myanmar 2
RO - Romania 2
SV - El Salvador 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
Totale 17.578
Salva come PNG Salva come JPEG
Città #
Jacksonville 954
Dublin 929
Chandler 927
San Jose 658
Nanjing 641
Ashburn 560
Singapore 556
Hong Kong 504
Beijing 382
Dallas 382
Boardman 307
Nanchang 231
Princeton 199
Lawrence 192
Shenyang 192
Wilmington 172
Lauterbourg 170
Hebei 163
Changsha 158
Ho Chi Minh City 155
Jiaxing 148
Ann Arbor 147
Los Angeles 144
Hangzhou 105
Medford 101
Hanoi 98
Helsinki 93
Tianjin 91
Shanghai 80
Moscow 75
New York 70
Redondo Beach 70
Buffalo 63
Council Bluffs 59
Johannesburg 55
Woodbridge 52
Munich 46
Milan 44
São Paulo 41
Houston 38
Norwalk 37
The Dalles 36
Tokyo 36
Santa Clara 33
Brussels 32
Frankfurt am Main 30
Orem 29
Falls Church 28
Kunming 27
Piscataway 27
Seattle 27
Washington 26
Fairfield 25
Haiphong 25
Atlanta 23
Brooklyn 23
London 23
Melbourne 23
Verona 23
Chennai 22
Chicago 22
Da Nang 22
Denver 21
Des Moines 21
Toronto 20
Baghdad 19
Dearborn 19
Montreal 19
Rio de Janeiro 19
Stockholm 19
Warsaw 19
Phoenix 18
Tappahannock 17
Boston 16
Mexico City 16
San Francisco 16
Zhengzhou 16
Manchester 15
Tashkent 15
Columbus 13
Karachi 13
Quito 13
Turku 13
Amsterdam 12
Jinan 12
Santiago 12
Coimbra 11
Guangzhou 11
Nairobi 11
Rome 11
Belo Horizonte 10
Brisbane 10
Changchun 10
Fuzhou 10
Guayaquil 10
Hải Dương 10
Pavia 10
Brasília 9
Dhaka 9
Falkenstein 9
Totale 11.185
Salva come PNG Salva come JPEG
Nome #
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 574
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. 238
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 180
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 165
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis. 163
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 161
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. 153
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. 142
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 142
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 141
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 140
Assessment and management of pulmonary alveolar proteinosis in a reference center. 139
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. 137
Advances in proteomic techniques for biomarker discovery in COPD 137
Familial elevation of serum angiotensin converting enzyme activity. 132
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles. 131
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis 130
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. 124
A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. 123
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 123
alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. 120
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. 120
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? 120
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 119
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 117
Some properties of the alkaline proteinase from Aspergillus melleus. 117
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 117
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 116
HLA markers in sarcoidosis. 116
A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. 116
Studies of MR 889, a new synthetic proteinase inhibitor. 116
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 114
A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene. 112
Identification and characterisation of eight novel SERPINA1 null mutations. 111
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 110
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 109
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 109
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 108
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 108
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. 107
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. 106
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. 106
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 106
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 105
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. 105
A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. 103
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 102
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 102
Alpha-1 antitrypsin deficiency: from Italy to the world. 102
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 101
Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. 101
Complement receptor 1 gene polymorphisms in sarcoidosis. 101
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 101
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 101
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. 101
Mechanisms of lung injury in cystic fibrosis. 100
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 100
Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients. 97
α₁-Antitrypsin level and pheno/genotypes 97
Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. 96
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 95
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. 95
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 95
Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. 94
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 94
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 93
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 93
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 92
Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. 92
High performance capillary electrophoresis in the study of proteinase activity and of markers of lung destruction. 91
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 91
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 91
On the activity of MR 889, a new synthetic proteinase inhibitor. 90
Micellar Electrokinetic Chromatography with Laser Induced Detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: A comparative analysis. 90
HLA Class I, II and III polymorphisms in sarcoidosis. 89
COPD: no gene left unturned 89
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. 89
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 88
Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. 87
Biochemical and functional markers of lung damage after bleomycin treatment. 87
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 87
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 86
Lung cancer in young adults. 85
You may say that I ain't free--but it don't worry me. 85
Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis. 85
Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004–2013. 84
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 84
Interactions of P 1507, a new antioxidant agent, with phagocyte functions. 83
Secondary outputs of alpha1-antitrypsin deficiency targeted detection programme. 83
Sarcoidosis of the thyroid: report of a case and a review of the literature. 83
Early response of gene clusters is associated with mouse lung resistance or sensitivity to cigarette smoke. 83
HLA and sarcoidosis: new pathogenetic insights. 82
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 82
Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. 82
Introduction: the history of the Alpha One International Registry (A.I.R.). 82
Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. 82
Interactions of alpha-1-antichymotrypsin, alpha-1-proteinase inhibitor, and alpha-2-macroglobulin with the fungal enzyme, seaprose. 82
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. 80
Influence of a secondary genetic factor in cystic fibrosis genotype-phenotype correlations. 80
Report of one case of familial sarcoidosis. 80
Totale 11.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022727 18 5 5 16 17 26 22 60 49 10 126 373
2022/20232.658 284 184 19 225 319 276 0 153 1.061 22 71 44
2023/2024955 102 180 43 67 109 199 14 50 8 68 73 42
2024/20252.422 80 225 70 121 51 89 83 249 559 83 244 568
2025/20265.526 366 379 710 647 632 281 1.098 187 484 462 195 85
Totale 17.673